» Articles » PMID: 15920350

Inactivation of Hantaan Virus-containing Samples for Subsequent Investigations Outside Biosafety Level 3 Facilities

Overview
Journal Intervirology
Specialty Microbiology
Date 2005 May 28
PMID 15920350
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The potential risk of accidental infection by hantaviruses in a clinical or research laboratory necessitates special precautionary measures. A biosafety program must address handling and disposal of infectious materials as well as appropriate virus inactivation or depletion procedures to permit necessary further processing of specimens outside the biosafety level 3 laboratory.

Methods: To study the elimination of hantavirus infectivity, the effects of different chemical and physical inactivation and depletion procedures were investigated on Hantaan virus-containing materials. An infectivity assay for hantaviruses was utilised to verify these procedures which are commonly preceding investigations such as ELISA, flow cytometry analysis, Western blot or immunofluorescence assay.

Results: Chemical inactivation with methanol, paraformaldehyde, acetone/methanol and detergent-containing lysis buffer as well as physical forces such as UV irradiation and filtration efficiently reduced viral infectivity in infected cells and their supernatants below the detection limit.

Conclusion: The virus inactivation and depletion methods described herein are suitable to prepare non-infectious samples for further use in immunological, virological and cell-biological assays.

Citing Articles

Seoul orthohantavirus evades innate immune activation by reservoir endothelial cells.

Klimaj S, LaPointe A, Martinez K, Acosta E, Kell A PLoS Pathog. 2024; 20(11):e1012728.

PMID: 39585900 PMC: 11627401. DOI: 10.1371/journal.ppat.1012728.


Crude Extracts of Strains (Ascomycota) Affect Honey Bee () Resistance to Chronic Bee Paralysis Virus.

Vocadlova K, Lamp B, Benes K, Matha V, Lee K, Vilcinskas A Viruses. 2023; 15(2).

PMID: 36851556 PMC: 9958978. DOI: 10.3390/v15020343.


Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Elveborg S, Monteil V, Mirazimi A Pathogens. 2022; 11(2).

PMID: 35215213 PMC: 8879476. DOI: 10.3390/pathogens11020271.


Biodefense Implications of New-World Hantaviruses.

DSouza M, Patel T Front Bioeng Biotechnol. 2020; 8:925.

PMID: 32850756 PMC: 7426369. DOI: 10.3389/fbioe.2020.00925.


Replication in the Mononuclear Phagocyte System (MPS) as a Determinant of Hantavirus Pathogenicity.

Raftery M, Lalwani P, Lutteke N, Kobak L, Giese T, Ulrich R Front Cell Infect Microbiol. 2020; 10:281.

PMID: 32596167 PMC: 7304325. DOI: 10.3389/fcimb.2020.00281.